As small radiation fields play an ever-increasing role in radiation therapy, accurate dosimetry of these fields becomes critical to ensure high quality dose calculation and treatment optimization. The PRB-0002, a new plastic scintillation detector (PSD) part of the Hyperscint RP-200 dosimetric platform from Medscint, can potentially facilitate small field measurements. In this work our objective is twofold: first we perform a detailed characterization of the field output correction factors of the PRB-0002 over a wide range of field sizes; second we demonstrate how this PSD can be used to determine the field output correction factors for other small field detectors. Uncertainties were carefully considered and a detailed uncertainty budget is provided. EGSnrc Monte Carlo simulations were conducted to determine the impact of detector composition, surrounding materials, dose averaging within the sensitive volume as well as ionization quenching. From these simulations, the field output correction factors of this PSD were determined. Then, by experimental comparisons, field output correction factors for 2 solid state detectors and 3 small volume ion chambers were. With PRB-0002, the material composition was found to be balanced with the ionization quenching making the field output correction factor near unity. For fields between 0.6 × 0.6 and 30 × 30 cm^2, the field output correction factors of the PRB-0002 were between 1.002 and 0.999 with a total uncertainty of 0.5 uncertainty budget showed that an overall uncertainty of 0.59 for a 1 × 1 cm^2 using PRB-0002. We conclude that PRB-0002 is a near-ideal detector for small field dosimetry. Furthermore, it can be used to experimentally determine the field output correction factors of other dosimeters with great accuracy.

PURPOSEMedical linear accelerators (linac) are delivering increasingly complex treatments using modern techniques in radiation therapy. Complete and precise mechanical QA of the linac is therefore necessary to ensure that there is no unexpected deviation from the gantry's planned course. However, state-of-the-art EPID-based mechanical QA procedures often neglect some degrees of freedom (DOF) like the in-plane rotations of the gantry and imager or the source movements inside the gantry head. Therefore, the purpose of this work is to characterize a 14 DOF method for the mechanical QA of linacs. This method seeks to measure every mechanical deformation in a linac, including source movements, in addition to relevant clinical parameters like mechanical and radiation isocenters.METHODSA widely available commercial phantom and a custom-made accessory inserted in the linac's interface mount are imaged using the electronic portal imaging device (EPID) at multiple gantry angles. Then, simulated images are generated using the nominal geometry of the linac and digitized models of the phantoms. The nominal geometry used to generate these images can be modified using 14 DOF (3 rigid rotations and 3 translations for the imager and the gantry, and 2 in-plane translations of the source) and any change will modify the simulated image. The set of mechanical deformations that minimizes the differences between the simulated and measured image is found using a genetic algorithm coupled with a gradient-descent optimizer. Phantom mispositioning and gantry angular offset were subsequently calculated and extracted from the results. Simulations of the performances of the method for different levels of noise in the phantom models were performed to calculate the absolute uncertainty of the measured mechanical deformations. The measured source positions and the center of collimation were used to define the beam central axis and calculate the radiation isocenter position and radius.RESULTSAfter the simultaneous optimization of the 14 DOF, the average distance between the center of the measured and simulated ball bearings on the imager was 0.086 mm. Over the course of a full counter-clockwise gantry rotation, all mechanical deformations were measured, showing sub-millimeter translations and rotations smaller than 1° along every axis. The average absolute uncertainty of the 14 DOF (1 SD) was 0.15 mm or degree. Phantom positioning errors were determined with more than 0.1 mm precision. Errors introduced in the experimental setup like phantom positioning errors, source movements or gantry angular offsets were all successfully detected by our QA method. The mechanical deformations measured are shown to be reproducible over the course of a few weeks and are not sensitive to the experimental setup.CONCLUSIONThis work presents of new method for an accurate mechanical QA of the linacs. It features a 14 DOF model of the mechanical deformations that is both more complete and precise than other available methods. It has demonstrated sub-millimeter accuracy through simulation and experimentation. Introduced errors were successfully detected with high precision.

PURPOSE:The movements of the prostate relative to the pelvic lymph nodes during intensity-modulated radiation therapy treatment can limit margin reduction and affect the protection of the organs at risk (OAR). In this study, the authors performed an analysis of three adaptive treatment strategies that combine information from both bony and gold marker registrations. The robustness of those treatments against the interfraction prostate movements was evaluated.METHODS:A retrospective study was conducted on five prostate cancer patients with 7-13 daily cone-beam CTs (CBCTs). The clinical target volumes (CTVs) consisting of pelvic lymph nodes, prostate, and seminal vesicles as well as the OARs were delineated on each CBCT and the initial CT. Three adaptive strategies were analyzed. Two of these methods relied on a two-step patient positioning at each fraction. First step: a bony registration was used to deliver the nodal CTV prescription. Second step: a gold marker registration was then used either to (1) complete the dose delivered to the prostate (complement); (2) or give almost the entire prescription to the prostate with a weak dose gradient between the targets to compensate for possible motions (gradient). The third method (COR) used a pool of precalculated plans based on images acquired at previous treatment fractions. At each new fraction, a plan is selected from that pool based on the daily position of prostate center-of-mass. The dosimetric comparison was conducted and results are presented with and without the systematic shift in the prostate position on the CT planning. The adaptive strategies were compared to the current clinical standard where all fractions are treated with the initial nonadaptive plan.RESULTS:The minimum daily prostate D95% is improved by 2%, 9%, and 6% for the complement, the gradient, and the COR approaches, respectively, compared to the nonadaptive method. The average nodal CTV D95% remains constant across the strategies, except for the gradient approach where a reduction of 7% is observed. However, a correction of the systematic shift reduced the problem, and the adaptive strategies remain robust against the prostate movement across the fraction. The bladder V55Gy is reduced by 35% on average for the adaptive strategies.CONCLUSIONS:Because they offer increased CTV coverage and OAR sparing, adaptive methods may be suitable candidates for simple and efficient adaptive treatment strategies for prostate cancer. Margin reduction and systematic error correction in the prostate position improve the protection of the OAR and the dose coverage. A cumulative dose to simulate a complete treatment would show real effects and allow a better comparison between each method.

PURPOSE:Patient-specific quality assurance (QA) of dynamic radiotherapy delivery would gain from being performed using a 3D dosimeter. However, 3D dosimeters, such as gels, have many disadvantages limiting to quality assurance, such as tedious read-out procedures and poor reproducibility. The purpose of this work is to develop and validate a novel type of high resolution 3D dosimeter based on the real-time light acquisition of a plastic scintillator volume using a plenoptic camera. This dosimeter would allow for the QA of dynamic radiation therapy techniques such as intensity-modulated radiation therapy (IMRT) or volumetric-modulated arc therapy (VMAT).METHODS:A Raytrix R5 plenoptic camera was used to image a 10 × 10 × 10 cm(3) EJ-260 plastic scintillator embedded inside an acrylic phantom at a rate of one acquisition per second. The scintillator volume was irradiated with both an IMRT and VMAT treatment plan on a Clinac iX linear accelerator. The 3D light distribution emitted by the scintillator volume was reconstructed at a 2 mm resolution in all dimensions by back-projecting the light collected by each pixel of the light-field camera using an iterative reconstruction algorithm. The latter was constrained by a beam's eye view projection of the incident dose acquired using the portal imager integrated with the linac and by physical consideration of the dose behavior as a function of depth in the phantom.RESULTS:The absolute dose difference between the reconstructed 3D dose and the expected dose calculated using the treatment planning software Pinnacle(3) was on average below 1.5% of the maximum dose for both integrated IMRT and VMAT deliveries, and below 3% for each individual IMRT incidences. Dose agreement between the reconstructed 3D dose and a radiochromic film acquisition in the same experimental phantom was on average within 2.1% and 1.2% of the maximum recorded dose for the IMRT and VMAT delivery, respectively.CONCLUSIONS:Using plenoptic camera technology, the authors were able to perform millimeter resolution, water-equivalent dosimetry of an IMRT and VMAT plan over a whole 3D volume. Since no moving parts are required in the dosimeter, the incident dose distribution can be acquired as a function of time, thus enabling the validation of static and dynamic radiation delivery with photons, electrons, and heavier ions.

Purpose: 3D dosimetry is recognized as an ideal for patient‐specific quality assurance (QA) of highly conformal radiotherapy treatments. However, existing 3D dosimeters are not straightforward to implement in the clinic, as their read‐out procedure is often tedious and their accuracy, precision, and/or sample size exhibit limitations. The purpose of this work is to develop a 3D dosimeter based on the concept of tomodosimetry inside concentric cylindrical planes using long scintillating fibers for the QA of modern radiotherapy techniques such as intensity‐modulated radiation therapy (IMRT) or intensity‐modulated arc therapy (IMAT).Methods: Using a model‐based simulation, scintillating fibers were modeled on three concentric cylindrical planes of radii 2.5, 5.0, and 7.5 cm, inside a 10 cm radius water‐equivalent cylinder phantom. The phantom was set to rotate around its central axis, made parallel to the linac gantry axis of rotation. Light acquisitions were simulated using the calculated dose from the treatment planning software and reconstructed in each cylindrical plane at a resolution of 1 mm2 using a total‐variation minimization iterative reconstruction algorithm. The 3D dose was then interpolated from the reconstructed cylindrical plane doses at a resolution of 1 mm3. Different scintillating fiber patterns were compared by varying the angle of each fiber in its cylindrical plane and introducing a light‐tight cut in each fiber. The precision of the reconstructed cylindrical dose distribution was evaluated using a Poisson modeling of the acquired light signals and the accuracy of the interpolated 3D dose was evaluated using an IMRT clinical plan for a prostate case.Results: Straight scintillating fiber patterns with light‐tight cuts were the most accurate in cylindrical dose reconstruction, showing less than 0.5 mm distance‐to‐agreement in dose gradients and a mean local dose difference of less than 0.2% in the high dose region for a 10 × 10 cm2 field. The precision attained with this fiber configuration was less than 0.9% in the high dose, low gradient region of an IMRT segment for light acquisitions of 0.1 MU over a 360 degree rotation of the cylinder phantom. 3D dose interpolation for the IMRT clinical plan yielded an overall dose difference with the reference input of less than 1%, except in high dose gradients.Conclusions: Using long scintillating fibers inside rotating, concentric cylindrical planes, the authors demonstrate that their tomodosimetry method has the potential for high resolution, precise, and accurate 3D dosimetry. Moreover, because of its water‐equivalence and rotational symmetry, this design should find interesting application for both treatment QA and machine commissioning.

The purposes of this work are to assess the performance of a 2D plastic scintillation detectors array prototype for quality assurance in intensity-modulated radiation therapy (IMRT) and to determine its sensitivity and specificity to positioning errors of one multileaf collimator (MLC) leaf and one MLC leaf bank by applying the principles of signal detection theory. Ten treatment plans (step-and-shoot delivery) and one volumetric modulated arc therapy plan were measured and compared to calculations from two treatment-planning systems (TPSs) and to radiochromic films. The averages gamma passing rates per beam found for the step-and-shoot plans were 95.8% for the criteria (3%, 2 mm), 97.8% for the criteria (4%, 2 mm), and 98.1% for the criteria (3%, 3 mm) when measurements were compared to TPS calculations. The receiver operating characteristic curves for the one leaf errors and one leaf bank errors were determined from simulations (theoretical upper limits) and measurements. This work concludes that arrays of plastic scintillation detectors could be used for IMRT quality assurance in clinics. The use of signal detection theory could improve the quality of dosimetric verifications in radiation therapy by providing optimal discrimination criteria for the detection of different classes of errors.

PURPOSE:Patient-specific QA of highly conformal radiotherapy treatments are usually conducted using 2D or 3D dosimetry of the incident dose distribution in a water-equivalent phantom. However, dosimeters typically used for this task usually lack in either spatial resolution or dose accuracy. The purpose of this work is to develop and validate a novel type of high resolution 2D dosimeter based on the tomographic reconstruction of the dose projections obtained using long scintillating fibers for the quality assurance of modern radiotherapy techniques such as IMRT.METHODS:Fifty parallel scintillating fibers were aligned in a 30 cm diameter cylindrical masonite phantom with a 95 cm source-to-surface distance and a 100 cm source-to-fibers distance. The fibers were disposed so that the effective detection area of the scintillating fibers was a 20 cm diameter disk. Both ends of each scintillating fiber were coupled to clear optical fibers to enable light collection by a single CCD camera. Seven IMRT segments and two square fields were acquired using 18 projections over a 170° rotation of the device. Computation of the dose integrals was made for each scintillating fiber using the irradiation of known rectangular reference fields. Dose reconstructions were conducted using a total-variation minimization iterative reconstruction algorithm. Eight monitor units were programmed for each projection and the reconstructed dose grid pixel resolution was set to 1 × 1 mm(2).RESULTS:3%∕3 mm gamma tests conducted between the reconstructed IMRT dose distributions and the dose calculated with the treatment planning system Pinnacle(3) were on average successful for 99.6% of the dose pixels with a predicted dose of at least 10% of the maximum dose. The dose profiles for both square fields and IMRT segments agreed within 2% to the dose calculated with Pinnacle(3) except in high dose gradient regions, and were comparable to the dose measured using an ionization chamber array (IBA MatriXX) and radiographic films (Kodak XV2).CONCLUSIONS:Using tomographic reconstruction on the projections acquired with rotating scintillating fibers, we were able to perform water-equivalent 2D dosimetry of square fields and IMRT segments with acceptable accuracy and high spatial resolution. The underlying concept of tomographic dosimetry and the small number of fibers needed to reconstruct a given 2D dose distribution offer new dosimetric possibilities, both applicable to 2D and 3D dosimetry.

Proton therapy offers the advantages of a superior target dose conformality and lower integral dose over the conventional photon therapy. However, range uncertainties associated with dose calculation approximations, tumor motion, setup variations, etc., present a major concern in proton therapy. In order to address this issue, we are developing a 2 mm resolution scintillating fiber detector with fibers arranged such that they form a 2D matrix that allows the determination of x- and y-position of the proton. By implementing a scheme consisting only of one detector positioned in front of the patient and another detector behind the patient, we can potentially realize a real-time measurement of proton position, direction, and range/energy simultaneously to reconstruct proton radiographs, also eliminating the need to use an additional bulky range telescope or calorimeter which is not appropriate for in vivo clinical use.

PURPOSE:To compare the performance of plastic scintillation detectors (PSD) for quality assurance (QA) in stereotactic radiosurgery conditions to a microion-chamber (IC), Gafchromic EBT2 films, 60 008 shielded photon diode (SD) and unshielded diodes (UD), and assess a new 2D crosshair array prototype adapted to small field dosimetry.METHODS:The PSD consists of a 1 mm diameter by 1 mm long scintillating fiber (BCF-60, Saint-Gobain, Inc.) coupled to a polymethyl-methacrylate optical fiber (Eska premier, Mitsubishi Rayon Co., Ltd., Tokyo, Japan). Output factors (S(c,p)) for apertures used in radiosurgery ranging from 4 to 40 mm in diameter have been measured. The PSD crosshair array (PSDCA) is a water equivalent device made up of 49 PSDs contained in a 1.63 cm radius area. Dose profiles measurements were taken for radiosurgery fields using the PSDCA and were compared to other dosimeters. Moreover, a typical stereotactic radiosurgery treatment using four noncoplanar arcs was delivered on a spherical phantom in which UD, IC, or PSD was placed. Using the Xknife planning system (Integra Radionics Burlington, MA), 15 Gy was prescribed at the isocenter, where each detector was positioned.RESULTS:Output Factors measured by the PSD have a mean difference of 1.3% with Gafchromic EBT2 when normalized to a 10 × 10 cm(2) field, and 1.0% when compared with UD measurements normalized to the 35 mm diameter cone. Dose profiles taken with the PSD crosshair array agreed with other single detectors dose profiles in spite of the presence of the 49 PSDs. Gamma values comparing 1D dose profiles obtained with PSD crosshair array with Gafchromic EBT2 and UD measured profiles shows 98.3% and 100.0%, respectively, of detector passing the gamma acceptance criteria of 0.3 mm and 2%. The dose measured by the PSD for a complete stereotactic radiosurgery treatment is comparable to the planned dose corrected for its SD-based S(c,p) within 1.4% and 0.7% for 5 and 35 mm diameter cone, respectively. Furthermore, volume averaging of the IC can be observed for the 5 mm aperture where it differs by as much as 9.1% compared to the PSD measurement. The angular dependency of the UD is also observed, unveiled by an under-response around 2.5% of both 5 and 35 mm apertures.CONCLUSIONS:Output Factors and dose profiles measurements performed, respectively, with the PSD and the PSDCA were in agreement with those obtained with the UD and EBT2 films. For stereotactic radiosurgery treatment verification, the PSD gives accurate results compared to the planning system and the IC once the latter is corrected to compensate for the averaging effect of the IC. The PSD provides precise results when used as a single detector or in a dense array, resulting in a great potential for stereotactic radiosurgery QA measurements.

PURPOSE:The objective of this work is to present a new 2D plastic scintillation detectors array (2D-PSDA) designed for the dosimetry of megavoltage (MV) energy photon beams in radiation therapy and to characterize its basic performance. METHODS:We developed a 2D detector array consisting of 781 plastic scintillation detectors (PSDs) inserted into a plane of a water-equivalent phantom. The PSDs were distributed on a 26 × 26 cm(2) grid, with an interdetector spacing of 10 mm, except for two perpendicular lines centered on the detection plane, where the spacing was 5 mm. Each PSD was made of a 1 mm diameter by 3 mm long cylindrical polystyrene scintillating fiber coupled to a clear nonscintillating plastic optical fiber. All of the light signals emitted by the PSDs were read simultaneously with an optical system at a rate of one measurement per second. We characterized the performance of the optical system, the angular dependency of the device, and the perturbation of dose distributions caused by the hundreds of PSDs inserted into the phantom. We also evaluated the capacity of the system to monitor complex multileaf collimator (MLC) sequences such as those encountered in step-and-shoot intensity modulated radiation therapy (IMRT) plans. We compared our results with calculations performed by a treatment planning system and with measurements taken with a 2D ionization chamber array and with a radiochromic film. RESULTS:The detector array that we developed allowed us to measure doses with an average precision of better than 1% for cumulated doses equal to or greater than 6.3 cGy. Our results showed that the dose distributions produced by the 6-MV photon beam are not perturbed (within ±1.1%) by the presence of the hundreds of PSDs located into the phantom. The results also showed that the variations in the beam incidences have little effect on the dose response of the device. For all incidences tested, the passing rates of the gamma tests between the 2D-PSDA and the treatment planning system were higher than 97.5% when the standard clinical tolerances of 3% or 3 mm were used. Excellent agreement was obtained between the doses measured and calculated when we used the 2D-PSDA for monitoring a MLC sequence from a step-and-shoot IMRT plan. CONCLUSIONS:We demonstrated the feasibility of using a large number of PSDs in a new 2D-PSDA for the dosimetry of MV energy photon beams in radiation therapy. The excellent precision, accuracy, and low angular dependence of the device indicate that such a prototype could potentially be used as a high-accuracy quality assurance tool for IMRT and arc therapy patient plan verification. The homogeneity and water-equivalence of the prototype we built suggest that this technology could be extended to multiple detection planes by arranging the fibers into more complex orientations, opening the possibility for 3D dosimetry with PSDs.

PURPOSE Multileaf collimator (MLC)-driven conformal radiotherapy modalities [e.g., such as intensity-modulated radiotherapy (IMRT), intensity-modulated arc therapy, and stereotactic body radiotherapy] are more subject to delivery errors and dose calculation inaccuracies than standard modalities. Fluence monitoring during treatment delivery could reduce such errors by allowing an independent interface to quantify and assess measured difference between the delivered and planned treatment administration. We developed an optical attenuation-based detector to monitor fluence for the on-line quality control of radiotherapy delivery. The purpose of the current study was to develop the theoretical background of the invention and to evaluate the detector's performance both statistically and in clinical situations. METHODS We aligned 60 27-cm scintillating fibers coupled to a photodetector via clear optical fibers in the direction of motion of each of the 60 leaf pairs of a 120 leaves Millenium MLC on a Varian Clinac iX. We developed a theoretical model to predict the intensity of light collected on each side of the scintillating fibers when placed under radiation fields of varying sizes, intensities, and positions. The model showed that both the central position of the radiation field on the fiber (x(c)) and the integral fluence passing through the fiber (phi(int)) could be assessed independently in a single measurement. We evaluated the performance of the prototype by (1) measuring the intrinsic variation of the measured values of x(c) and phi(int), (2) measuring the impact on the measured values of x(c) and phi(int) of random leaf positioning errors introduced into IMRT fields, and (3) comparing the predicted values of x(c) and phi(int) calculated with the treatment planning software to the measured values of x(c) and phi(int) in order to assess the predictive effectiveness of the developed theoretical model. RESULTS We observed a very low intrinsic dispersion, dominated by Poisson statistics, for both x(c) (standard deviations of less than 1 mm) and phi(int) (standard deviations of less than 0.20%). When confronted with random leaf positioning errors from IMRT segments, phi(int) was highly sensitive to single leaf positioning errors as small as 1 mm at isocenter, while x(c) was sensitive to leaf pair translation errors of at least 2 mm at isocenter. Owing to the uncertainties in the doses calculated in regions of high perpendicular dose gradients, the measured values of x(c) and phi(int) deviated from the predicted values of x(c) and phi(int) by a mean of 1.3 mm and 2.6%, respectively. CONCLUSION Our study showed that an optical attenuation-based detector can be used to effectively monitor integral fluence during radiotherapy delivery. The performance of such a system would enable real-time quality control of the incident fluence in current MLC-driven treatments such as IMRT and future adaptive radiotherapy procedures where new treatment plans will have to be delivered without passing thru the current standard quality control chain.

PURPOSE:This work presents the experimental extraction of the perturbation factor in megavoltage electron beams for three models of silicon diodes (IBA Dosimetry, EFD and SFD, and the PTW 60012 unshielded) using a plastic scintillation detector (PSD).METHODS:The authors used a single scanning PSD mounted on a high-precision scanning tank to measure depth-dose curves in 6-, 12-, and 18-MeV clinical electron beams. They also measured depth-dose curves using the IBA Dosimetry, EFD and SFD, and the PTW 60012 unshielded diodes. The authors used the depth-dose curves measured with the PSD as a perturbation-free reference to extract the perturbation factors of the diodes.RESULTS:The authors found that the perturbation factors for the diodes increased substantially with depth, especially for low-energy electron beams. The experimental results show the same trend as published Monte Carlo simulation results for the EFD diode; however, the perturbations measured experimentally were greater. They found that using an effective point of measurement (EPOM) placed slightly away from the source reduced the variation of perturbation factors with depth and that the optimal EPOM appears to be energy dependent.CONCLUSIONS:The manufacturer recommended EPOM appears to be incorrect at low electron energy (6 MeV). In addition, the perturbation factors for diodes may be greater than predicted by Monte Carlo simulations.

PURPOSE:The purposes of this work were: (1) To determine if a spectral method can accurately correct the Cerenkov light effect in plastic scintillation detectors (PSDs) for situations where the Cerenkov light is dominant over the scintillation light and (2) to develop a procedural guideline for accurately determining the calibration factors of PSDs. METHODS:The authors demonstrate, by using the equations of the spectral method, that the condition for accurately correcting the effect of Cerenkov light is that the ratio of the two calibration factors must be equal to the ratio of the Cerenkov light measured within the two different spectral regions used for analysis. Based on this proof, the authors propose two new procedures to determine the calibration factors of PSDs, which were designed to respect this condition. A PSD that consists of a cylindrical polystyrene scintillating fiber (1.6 mm3) coupled to a plastic optical fiber was calibrated by using these new procedures and the two reference procedures described in the literature. To validate the extracted calibration factors, relative dose profiles and output factors for a 6 MV photon beam from a medical linac were measured with the PSD and an ionization chamber. Emphasis was placed on situations where the Cerenkov light is dominant over the scintillation light and on situations dissimilar to the calibration conditions. RESULTS:The authors found that the accuracy of the spectral method depends on the procedure used to determine the calibration factors of the PSD and on the attenuation properties of the optical fiber used. The results from the relative dose profile measurements showed that the spectral method can correct the Cerenkov light effect with an accuracy level of 1%. The results obtained also indicate that PSDs measure output factors that are lower than those measured with ionization chambers for square field sizes larger than 25 x 25 cm2, in general agreement with previously published Monte Carlo results. CONCLUSIONS:The authors conclude that the spectral method can be used to accurately correct the Cerenkov light effect in PSDs. The authors confirmed the importance of maximizing the difference of Cerenkov light production between calibration measurements. The authors also found that the attenuation of the optical fiber, which is assumed to be constant in the original formulation of the spectral method, may cause a variation of the calibration factors in some experimental setups.

PURPOSE:This work presents the experimental extraction of the overall perturbation factor PQ in megavoltage electron beams for NACP-02 and Roos parallel-plate ionization chambers using a plastic scintillation detector (PSD).METHODS:The authors used a single scanning PSD mounted on a high-precision scanning tank to measure depth-dose curves in 6, 12, and 18 MeV clinical electron beams. The authors also measured depth-dose curves using the NACP-02 and PTW Roos chambers.RESULTS:The authors found that the perturbation factors for the NACP-02 and Roos chambers increased substantially with depth, especially for low-energy electron beams. The experimental results were in good agreement with the results of Monte Carlo simulations reported by other investigators. The authors also found that using an effective point of measurement (EPOM) placed inside the air cavity reduced the variation of perturbation factors with depth and that the optimal EPOM appears to be energy dependent.CONCLUSIONS:A PSD can be used to experimentally extract perturbation factors for ionization chambers. The dosimetry protocol recommendations indicating that the point of measurement be placed on the inside face of the front window appear to be incorrect for parallel-plate chambers and result in errors in the R50 of approximately 0.4 mm at 6 MeV, 1.0 mm at 12 MeV, and 1.2 mm at 18 MeV.

Optimal choice of beam energy in radiation therapy is easy in many well‐documented cases, but less obvious in some others. Low‐energy beams may provide better conformity around the target than their high‐energy counterparts due to reduced lateral scatter, but they also contribute to overdosage of peripheral normal tissue. Beam energy was added as an optimization parameter in an automatic aperture‐based inverse planning system. We have investigated a total of six cases for two sites (prostate and lung), representative of deep‐seated and moderately deep‐seated tumors. For one case for each site, different numbers of beam incidences were considered. The other cases for each site were optimized using a fixed number of incidences. Four types of plans were optimized: 6 MV, 23 MV, and mixed energy plans with one or two energies per incidence. Each plan was scored with a dose‐volume cost function. Cost function values, number of segments, monitor units, dose‐volume parameters, and isodose distributions were compared. For the prostate and lung cases, energy mixing improved plans in terms of cost function values, with a more important reduction for a small number of beam incidences. Use of high energy allowed better peripheral tissue sparing, while keeping similar target coverage and sensitive structures avoidance. Low energy contribution to monitor units usually increased with the number of beam incidences. Thus, for deep‐seated and moderately deep‐seated tumors, energy optimization can produce interesting plans with less peripheral dose and monitor units than for low energy alone.PACS numbers: 87.55.de, 87.55.dk, 87.56.N‐

Total body irradiations (TBIs) are unusual radiation therapy techniques used to treat specific hematological diseases. Most TBI techniques use extended source to patient distances [source-to-skin distance (SSD)] to provide lateral or anteroposterior irradiations. Those techniques differ from one institution to the other since they need to be customized to accommodate for local material constraints. However, with those unusual techniques come additional challenges for dose calculation. The purpose of this study was to obtain an accurate (better than 4%) dose calculation model for extended source-to-skin distance (eSSD) treatment techniques, which will be used for TBI planning. The studied dynamic TBI technique has special aspects (eSSD, beam spoiler, large field, and out of field dose contribution) that need to be considered in dose calculation. The first part of this study presents an eSSD beam model commissioning in PINNACLE3 and its validation. The second part looks at the comparison between two dose calculation algorithms, the 3D pencil beam and the superposition-convolution algorithms implemented in THERAPLAN PLUS and PINNACLE3 , respectively. A regular linac beam was commissioned in each treatment planning system and an additional dedicated TBI beam model was implemented in PINNACLE3 . The comparison results indicate that the quality of the TBI treatment greatly depends on the treatment planning system and its beam commissioning. The superposition-convolution algorithm (PINNACLE3 ) provides a better dose calculation tool for TBI than the 3D pencil beam algorithm (THERAPLAN PLUS) with a maximum mean error of 2.2% on a dynamic treatment. The TBI specific beam model of PINNACLE3 (ESSP-P3) also improves the dose calculation. The maximum difference between calculations and measurements (depth doses and beam profiles) was 2% except for extreme cases (build-up region and depth of 20cm) where the error was higher. Output factor determination and the dose contribution outside the primary beam weaknesses were found in PINNACLE3 . Methods are proposed to overcome these limitations. With the correction method applied, the TBI specific beam model allows a maximum mean error of -0.68% on a dynamic treatment. Accurate TBI dose computation necessitates a good dose calculation algorithm combined with a realistic beam model. Inappropriate dose calculation could lead to an important over- or underdose estimation. No perfect algorithm and beam model were found, but methods are proposed to overcome some of the limitations. Those methods are simple and can be used for other eSSD treatment types.